Aquestive Therapeutics CEO Daniel Barber recorded a code X transaction involving 91,743 shares at $0.96 per share, leaving him with 677,317 shares. The transaction also reduced his derivative securities position to zero, a change equal to about 100.0% of his prior derivative holdings and relevant to investors tracking insider ownership.

Key Highlights

  • Barber Daniel held 677,317 shares after the transaction.
  • His derivative securities position fell to 0.
  • The transaction represented about 13.5% of his resulting share holding.

Aquestive Therapeutics, Inc. (NASDAQ: AQST) President and CEO Barber Daniel recorded a code X transaction involving 91,743 shares at $0.96 per share on September 8, 2026. His resulting Equity position stood at 677,317 shares. Barber’s resulting derivative securities position was 0.

Two Bases for the Transaction Percentages

The share transaction represented about 13.5% of Barber’s resulting share holding. The derivative securities transaction represented about 100.0% of his prior derivative securities holding, leaving a zero position afterward. The two percentages therefore use different ownership bases: resulting shares for the first measure and prior derivative securities for the second. These figures describe the reported change in Barber’s positions.